104 related articles for article (PubMed ID: 10709910)
1. Induction of urokinase-type plasminogen activator by lipopolysaccharide in PC-3 human prostatic cancer cells.
Ohta S; Niiya K; Sakuragawa N; Fuse H
Thromb Res; 2000 Mar; 97(5):343-7. PubMed ID: 10709910
[TBL] [Abstract][Full Text] [Related]
2. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
3. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
Gross TJ; Sitrin RG
J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin.
Yoshida E; Verrusio EN; Mihara H; Oh D; Kwaan HC
Cancer Res; 1994 Jun; 54(12):3300-4. PubMed ID: 8205553
[TBL] [Abstract][Full Text] [Related]
7. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
Iwamoto J; Takahashi K; Mizokami Y; Otsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokoube K; Matsuoka T
Dig Dis Sci; 2003 Dec; 48(12):2247-56. PubMed ID: 14714609
[TBL] [Abstract][Full Text] [Related]
8. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
Tao Y; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
[TBL] [Abstract][Full Text] [Related]
10. Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3.
Liu DF; Rabbani SA
Prostate; 1995 Nov; 27(5):269-76. PubMed ID: 7479394
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha.
Marshall BC; Xu QP; Rao NV; Brown BR; Hoidal JR
J Biol Chem; 1992 Jun; 267(16):11462-9. PubMed ID: 1597474
[TBL] [Abstract][Full Text] [Related]
12. Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein.
Rotem N; Axelrod JH; Miskin R
Mol Cell Biol; 1987 Feb; 7(2):622-31. PubMed ID: 3102944
[TBL] [Abstract][Full Text] [Related]
13. Monocyte urokinase expression: modulation by interleukins.
Gyetko MR; Wilkinson CC; Sitrin RG
J Leukoc Biol; 1993 May; 53(5):598-601. PubMed ID: 8501398
[TBL] [Abstract][Full Text] [Related]
14. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines.
Tanabe T
Hiroshima J Med Sci; 2000 Mar; 49(1):67-72. PubMed ID: 10824459
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells.
Iguchi K; Tatsuda Y; Usui S; Hirano K
Anticancer Res; 2007; 27(6B):3843-8. PubMed ID: 18225541
[TBL] [Abstract][Full Text] [Related]
16. Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Kiguchi T; Niiya K; Shibakura M; Miyazono T; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Nakata Y; Harada M
Int J Cancer; 2001 Sep; 93(6):792-7. PubMed ID: 11519039
[TBL] [Abstract][Full Text] [Related]
17. Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.
Wang Y; Dang J; Liang X; Doe WF
Clin Exp Metastasis; 1995 May; 13(3):196-202. PubMed ID: 7750207
[TBL] [Abstract][Full Text] [Related]
18. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.
Reuning U; Wilhelm O; Nishiguchi T; Guerrini L; Blasi F; Graeff H; Schmitt M
Nucleic Acids Res; 1995 Oct; 23(19):3887-93. PubMed ID: 7479032
[TBL] [Abstract][Full Text] [Related]
20. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]